City

Beijing (1)

Nanjing (1)

Paris (1)

Condition

Digestive System Cancer (3)

Breast Cancer (1)

Ear Cancer (1)

Lung Cancer (1)

Malignant Ascites (1)

Nose Cancer (1)

Solid Tumor, Adult (1)

Throat Cancer (1)

Overall Status

Active, not recruiting (1)

Recruiting (1)

Unknown status (1)

Sign in for free

Phase

n/a (1)

phase 1 (1)

Sponsor

Dongfang Hospital Beijing University of Chinese Medicine (1)

Institut Curie (1)

The First Affiliated Hospital with Nanjing Medical University (1)

Collaborator

Intervention

cinobufacini injection (1)

evaluation on skin toxicities (1)

Study Documents

Intervention Type

drug (1)

other (1)

Funder Type

Other (3)

Study Type

Interventional (2)

Observational (1)

digestive system cancer

Showing 1 - 3 of 3

Trials per page:

STUDY

CONDITIONS

INTERVENTIONS

LOCATIONS

LAST UPDATED

Body Composition and Digestive System Cancer Survival

Active, not recruiting

Digestive System Cancer

Nanjing, Jiangsu, China

The First Affiliated Hospital of Nanjing Medical University

Sep 19, 2023

Solid Tumor, Adult, Breast Cancer, Lung Cancer Trial in Paris (Evaluation on skin toxicities)

Recruiting

Solid Tumor, Adult
+6 more

Evaluation on skin toxicities

Paris, France

Institut Curie

Apr 19, 2021

Digestive System Cancer, Malignant Ascites Trial in Beijing (Cinobufacini Injection)

Unknown status

Digestive System Cancer
Malignant Ascites

Cinobufacini Injection

Beijing, Beijing, China

Oncology dept; Dongfang Hospital Affiliated to Beijing Universit

Aug 29, 2017